[82] The trial reported cumulative occurrence of major adverse cardiovascular events, a primary end-point event of the trial, for 569 of the 8803 patients in the semaglutide group, which were 6.5% of the participants, and for 701 of the 8801 patients in the placebo group, which were 8% of the participants, showing relative 18.8% less major adverse cardiovascular events, such as death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, occurring for participants who had received semaglutide in the trial relative to those who had received placebo over the course of around 48 months, or 34.213.7 months, which was the mean (SD) total duration of the participants in either group's exposure to the placebo or semaglutide during the trial
It also promotes collagen synthesis, strengthens the skin barrier, and helps plump skin while smoothing wrinkles
Decreasing glucagon release
Early studies suggest that it may support memory and learning by repairing neural pathways and promoting the connections among brain cells
[2] It nourishes your scalp and ensures the proper functioning of your hair follicles
Neuroprotective Properties: Offers protective benefits for the nervous system, which may help in recovering from nerve damage